Integrating biological vasculature into a multi-organ-chip microsystem by Schimek, Katharina et al.
Cite this: Lab Chip, 2013, 13, 3588
Integrating biological vasculature into a multi-organ-
chip microsystem3
Received 18th February 2013,
Accepted 7th May 2013
DOI: 10.1039/c3lc50217a
www.rsc.org/loc
Katharina Schimek,{a Mathias Busek,{ab Sven Brincker,a Benjamin Groth,a
Silke Hoffmann,a Roland Lauster,a Gerd Lindner,a Alexandra Lorenz,a Ulrike Menzel,c
Frank Sonntag,b Heike Walles,d Uwe Marxa and Reyk Horland*a
A chip-based system mimicking the transport function of the human cardiovascular system has been
established at minute but standardized microsystem scale. A peristaltic on-chip micropump generates
pulsatile shear stress in a widely adjustable physiological range within a microchannel circuit entirely
covered on all fluid contact surfaces with human dermal microvascular endothelial cells. This microvascular
transport system can be reproducibly established within four days, independently of the individual
endothelial cell donor background. It interconnects two standard tissue culture compartments, each of 5
mm diameter, through microfluidic channels of 500 mm width. Further vessel branching and vessel
diameter reduction down to a microvessel scale of approximately 40 mm width was realised by a two-
photon laser ablation technique applied to inserts, designed for the convenient establishment of
individual organ equivalents in the tissue culture compartments at a later time. The chip layout ensures
physiological fluid-to-tissue ratios. Moreover, an in-depth microscopic analysis revealed the fine-tuned
adjustment of endothelial cell behaviour to local shear stresses along the microvasculature of the system.
Time-lapse and 3D imaging two-photon microscopy were used to visualise details of spatiotemporal
adherence of the endothelial cells to the channel system and to each other. The first indicative long-term
experiments revealed stable performance over two and four weeks. The potential application of this
system for the future establishment of human-on-a-chip systems and basic human endothelial cell
research is discussed.
Introduction
The significant impact of endothelial cell (EC) co-culture to
emulate the functionality of an individual human tissue in
vitro has been proven in various ‘‘organ-on-a-chip’’ systems
over the last few years.1–5 Moreover, the success in individual
tissue culture microsystems has stimulated researchers to
challenge a more systemic level of human biology in vitro
through so-called ‘‘body-on-a-chip’’ or ‘‘human-on-a-chip’’
systems.6–9 Such systems aim to combine several organ
equivalents within a human-like metabolizing environment
or aim at in vivo-like pharmacokinetics and pharmacody-
namics. The most advanced of these microsystems – the micro
cell culture analogue (mCCA) of Shuler and co-workers10 –
supports the molecular interplay between individual liver,
bone-marrow and tumour cell culture compartments through
a media recirculation using an external pump and an external
common reservoir. Physiological flow velocity and substance
residence times can be maintained in that system at an
artificially high fluid-to-tissue ratio. The same solution for
media recirculation has been used in the multi-channel 3D-
micro fluid cell culture system (mFCCS) of Zhang and co-
workers to combine individual human liver, lung, kidney, and
adipose cell culture compartments.11 By contrast, the total
micro bioassay system of Imura and co-workers, in its most
advanced version, constitutively combines human intestine,
liver and breast cancer cell cultures in a single linear channel
applying unidirectional flow without media recirculation.12
The establishment of a functional on-chip organ equivalent
also requires a significant period of time – e.g. 18 days for the
most advanced lung equivalent on a chip;1 the effective
substance exposure time in most existing microsystems
usually ranges from 24 to 72 h and rarely exceeds 7 days.9
The total tissue cultivated within an individual tissue
compartment rarely exceeds 10,000 cells.
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Therefore, the existing ‘‘human-on-a-chip’’ or individual
‘‘organ-on-a-chip’’ solutions differ from human biology in two
pivotal aspects: the inability to provide unlimited tissue
homeostasis, and the lack of the physiological capabilities of
tissue repair. We hypothesize that a miniaturized equivalent to
the human blood vasculature is a major missing part in the
process of achieving such long-term homeostasis at a single
individual organ or multi-organ level on chips. The human
cardiovascular system is composed of two parts. The transport
part – heart and vessels – ensures lifelong pulsatile blood
perfusion of the capillaries in a recirculation mode. The
functional part – capillaries 1–4 mm long, 5–10 mm in
diameter – was designed by evolution so that maintenance
(nutrition and immune defence), crosstalk (hormones and
other messenger molecules) and repair (clotting and neoan-
giogenesis) of all organs of an individual organism is ensured.
Impressive demonstrations of the power of biological vascu-
lature for organ functionality has been provided through
implantation of in vitro tissue cultures back into in vivo
vasculature.13–15
We aimed to emulate the transport part of the human
vasculature – heart and vessels – on a chip to address this gap.
An on-chip micropump to support steady long-term fluid flow
through a microchannel system fully covered by primary
human dermal microvascular endothelial cells (HDMECs) was
established. In contrast to the majority of the existing
microsystems to investigate shear stress effects on ECs
applying steady shear stress in the range of 10–40 dyn
cm22,16–21 we aimed for pulsatile shear stress with reversing
patterns which had been used earlier in different experimental
settings.22–24 The microvascular transport system presented in
this work interconnects two separate compartments which are
designed for the future integration of individual organ
equivalents with a biomass capacity of up to 100 mg each.
Special inserts were fabricated supporting vessel branching
and diameter reduction in the areas of individual organ
culture compartments to support later organ vascularization.
Rapid prototyping applying soft lithography and replica
moulding of PDMS allows the flexible adjustment of the
design with regard to the number of organs and their specific
arrangement, always adhering to the same standard chip
basement format. Furthermore, two important features were
incorporated to overcome the technical handling restraints of
the majority of existing microfluidic systems: i) incubator
independent operation of the microsystem was assured by a
tempered chip support, and ii) microscopic access to each and
every area of the circuit channels was guaranteed, enabling
real-time video microscopy.
Materials and methods
Device design and fabrication
We designed and fabricated a microfluidic multi-organ-chip
(MOC) device accommodating two separate microvascular
circuits each operated by a separate peristaltic on-chip
micropump. Fig. 1 illustrates the system. The cover-plate
accommodates six air pressure fittings and four inserts
forming 300 ml compartments, each for media exchange and
later integration of organ equivalents (Fig. 1b). The MOC-
holder supports controlled constant tempering of the MOC at
37 uC (Fig. 1a). Peristaltic on-chip micropumps (Fig. 1c) were
modified from Wu and co-workers.25 Micropump software
control facilitates both clockwise and anti-clockwise fluid flow.
The flow rate (Q) can be varied by the adjustment of the
pumping frequency. Each microchannel circuit (Fig. 1d)
comprises a total volume of 10 ml while the two individual
insert-based compartments for further organ equivalent
culture each have a volumetric capacity of up to 300 ml.
Standard soft lithography and replica moulding of PDMS
(Sylgard 184, Dow Corning, Midland, MI, USA) were been
applied for MOC fabrication. In brief, a master mould was
fabricated by bonding a silicon wafer to a glass wafer.
Photoresist was applied to the silicon wafer and patterned by
using a photomask and UV light. Subsequently unprotected
silicon regions were etched and the photoresist was stripped.
To fabricate the microsystem, the cover-plate (CP) was treated
with a silicon rubber additive (WACKER1 PRIMER G 790;
Wacker Chemie, Munich, Germany) at 80 uC for 20 min. The
prepared cover-plate was plugged to the master mould
(channel height 100 mm, width 500 mm) and PDMS (10 : 1 v/v
ratio of PDMS to curing agent) was injected into this casting
station. The set-up was incubated at 80 uC for at least 60 min.
Teflon screws were used to generate the four PDMS-free
culture compartments and the six 500 mm thick PDMS
membranes constituting the two on-chip micropumps (three
membranes per micropump). The cast PDMS slice bonds fluid-
tight to the CP. Thereafter, the PDMS slice attached to the CP
was irreversibly bonded by low pressure plasma oxidation
treatment (Femto; Diener, Ebhausen, Germany) to a micro-
scope slide. The sterile medium was injected immediately into
the two microvascular circuits to avoid surface neutralization.
Characterization of fluid dynamics
We applied non-invasive micro-particle image velocimetry
(mPIV), reviewed in detail elsewhere,26 to characterize the fluid
flow in spots A and B (cf. Fig. 1d) of the microfluidic circuit. In
brief, a Zeiss Primovert inverting microscope (Zeiss, Jena,
Germany) with a standard halogen lamp as a continuous light-
source, coupled to a CMOS-camera (Baumer HXC40, resolu-
tion: 2048 6 2048 pixel, interface: CameraLink; Baumer
Optronic, Radeberg, Germany) was used to track the move-
ment of 15 mm polystyrene beads (4 6 104 g ml21; Life
Technologies, Darmstadt, Germany) at an exposure time of 4
ms per single image. A low magnification (46) was chosen to
constrain the shift between two frames to approximately 50
pixels (1 pixel = 3.2 mm). The z-focus was set to the centre of the
fluidic channel in the respective spot (50 mm above the glass
slide) to detect the peak velocity. A window at the centre of the
fluidic channel (1024 pixel6 100 pixel, 3.28 mm6 0.32 mm)
was observed achieving frame rates up to 3200 fps. Finally, the
correlation was carried out with a software programme
(Fraunhofer IWS, Dresden, Germany) which analyses an image
stack of 15,000 frames, calculating the correlation maximum
for the x-component of the displacement in a specified area.
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The calculated values of five successive frames were averaged
to minimize artefacts. The following pump configuration was
used for all experiments: pressure 500 mbar; vacuum 2520
mbar; and air flow 1.5 l min21 at 350 mbar.
The time-dependency was measured at two different places
(A and B) on the chip, as shown in Fig. 1d.
The average shear stress at the channel walls with a
volumetric flow of Q can be calculated by27
tcells~
6:m:Q
h2:w
(1)
for a rectangular channel (width w, height h) and the dynamic
viscosity m. The volumetric flow rate is equal to the mean flow
velocity through the channel area:
Q = w?h?v¯ = w?h?k?vmax (2)
A calibration was carried out to determine the dependency
between velocity maximum (vmax) and mean velocity. The fluid
was pumped through the channel with a syringe pump to
ensure a steady and well-defined volumetric flow rate. By
varying Q, a coefficient k of 2/3 was measured.
This led to the following well-defined relationship between
peak velocity and wall shear stress:27
tcells~
4:m:vmax
h
(3)
where vmax is the magnitude of the averaged velocity at the
centre of the channel, m is the dynamic viscosity (calculated as
1 mPa s21) and h is the channel height (100 mm).
Cell isolation and culture
HDMECs were isolated from human foreskin obtained with
informed consent and ethics approval (Ethic Committee
Charite´ University Medicine,Berlin, Germany) from a paedia-
tric surgery after routine circumcisions of juvenile donors. All
skin samples used for cell isolation were processed within one
day of their removal. Prior to isolation, the foreskins were
cleaned in 80% ethanol for 30 s and rinsed with phosphate
buffered saline (PBS; PAA, Coelbe, Germany). The skin-ring
was opened and subcutaneous tissue was removed. In order to
separate the thin epidermal layer from the dermis, the
prepared foreskin was incubated in 5 mg ml21 dispase II
solution (Sigma-Aldrich, Schnelldorf, Germany) at 4 uC for 15–
18 h. The dermis was cut into small pieces and then incubated
with 4 mg ml21 Collagenase NB 4 solution (Serva, Heidelberg,
Germany) at 37 uC for 75 min. The mixture was passed through
a 70 mm nylon filter and centrifuged at 300 g for 5 min. The
resulting cell pellet was resuspended in Endothelial Cell
Growth Medium MV2 (ECGM-MV2; PromoCell, Heidelberg,
Germany) supplemented with Supplement-Pack MV2
(PromoCell, Heidelberg, Germany), 1% Penicillin-
Streptomycin (P-S) and 0.05% fungizone. The cells were
seeded into a T-75 flask and grown in 5% CO2 at 37 uC. The
medium was replaced one day after seeding. Two to five days
after the initial seeding, the HDMECs were purified by
magnetic associated cell sorting (MACS). Cells were harvested
using 0.05% (0.5 mg ml21) Trypsin/EDTA (PAA, Coelbe,
Germany) and a positive selection for ECs using the CD31
MicroBead Kit (Miltenyi Biotec, Bergisch Gladbach, Germany)
was performed according to the manufacturer’s instructions.
ECGM-MV2 supplemented with Supplement-Pack MV2 and
1% P-S (complete ECGM-MV2) was used to elude the cells from
Fig. 1 The microfluidic MOC device at a glance. (a) Exploded view of the device comprising a polycarbonate CP (blue), the PDMS-glass chip accommodating two
microvascular circuits (yellow; footprint: 76 mm 6 25 mm; height: 3 mm) and a heatable MOC-holder (red). (b) Section through the tissue culture compartment
supporting media exchange and cell/tissue cultures directly in the fluid flow. (c) Cross-section of a peristaltic on-chip micropump operated by programmed periodic
compression and decompression of three successively arranged PDMS membranes (thickness: 500 mm); the arrow indicates the direction of flow. (d) Top view of the
MOC layout illustrating the two separate microfluidic circuits (channel height: 100 mm; width: 500 mm) each accommodating two insert areas (compartments) (insert
diameter: 5 mm). Spots A and B of each circuit designate the position of non-invasive fluid flow and cell analysis.
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the column. A purity control of the isolated cells was
performed directly after each MACS by FACS analyses. Where
necessary, separation cycles were repeated until .90% of the
cells were positive for CD31. The purified HDMECs were either
frozen for later use or used immediately after expansion.
HDMECs were expanded in T-75 flasks with complete ECGM-
MV2 until 70–90% confluence at a three day feeding regimen.
Cells between the 3rd and 8th passage were used for all studies
to ensure that the cells retained their primary endothelial
characteristics.
Culture of HDMECs on differently treated PDMS surfaces
HDMECs were seeded at a density of 104 cells cm22 on three
types of PDMS surface: untreated, coated with 100 mg ml21
fibronectin (Sigma Aldrich, Schnelldorf, Germany) and treated
with air plasma. Air plasma treatment was performed in a low
pressure plasma system (50 W) at a frequency of 13.56 MHz for
30 s. After 48 h of cultivation, growth behaviour and
morphology of the cells was compared by light microscopy.
EC seeding and culture in the MOC
Prior to seeding, each MOC was flushed with medium and
incubated statically for 3 days in 5% CO2 at 37 uC. HDMECs
were harvested from expansion cultures using 0.05% Trypsin/
EDTA (PAA, Coelbe, Germany). The cell suspension was
concentrated by centrifugation and cell counts were performed
using the ViCell viability counter (Beckman Coulter, Fullerton,
CA, USA). Cell viability was .90% for all experiments.
Centrifuged cells were resuspended with complete ECGM-
MV2 to a final concentration of 26 107 cells ml21. Afterwards,
the cell suspension was transferred to a 1 ml syringe. The cells
were injected through one of the two compartments of each
circuit. The syringe was connected to a female Luer 6 J–28
male adapter (IDEX Health & Science, Wertheim-Mondfeld,
Germany). Air was pushed out of this fitting, which was then
screwed to a special thread (MOC) adapter (MicCell MOC-IJ–
28 UNF6 M10 Fitting (PEEK); Gesim, Dresden, Germany). An
empty syringe was connected in the same way to the second
compartment. After even cell infusion into both circuits the
device was incubated in 5% CO2 at 37 uC under static
conditions for 3 h to allow the cells to attach to the channel
walls. An amount of 300 ml fresh medium was added to each
compartment and then flushed through the PDMS channels
using the on-chip micropump of each circuit. A frequency of
0.476 Hz was applied to every microvascular circuit of the
MOCs for continuous dynamic operation. For MOC cultures
under static conditions, the channels were flushed with fresh
medium for 5 min, utilising a difference in hydrostatic
pressure between the inlet and outlet compartment.
An amount of 150 ml medium per compartment was
replaced every 1–2 days in both dynamic and static MOC
systems, and cell growth and viability were monitored by light
microscopy inspection at spots A and B of each circulation
(Fig. 1d). In addition, cell viability was determined with a
Calcein AM assay. A solution of 5 mg ml21 CellTraceTM calcein
red-orange AM (Life Technologies, Darmstadt, Germany) was
added into both compartments of each circuit of a MOC at a
volume of 100 ml. The MOC was pumped for 2 min and then
incubated under static conditions in 5% CO2 at 37 uC for 30
min. Thereafter, the microchannels were washed twice with
medium by replacing the medium in the compartment inserts
with fresh medium. Images were obtained using a fluores-
cence microscope (BZ9000; Keyence, Neu-Isenburg, Germany).
Regular MOC experiments were finished after 4 days (10
dynamic MOCs and 12 static MOCs). Individual MOCs were
operated at the same mode over 7, 14 and 32 days to gain first
indications of the long term performance of the microvascular
circuits. In order to evaluate the possibility of replacing the
CO2-incubator for MOC operation by the MOC-holder shown
in Fig. 1a, 9 MOC experiments (7 dynamic MOCs and 2 static
MOCs) were performed using the holder exclusively for
operation times of up to 7 days.
Characterization of EC metabolism in the MOC
The glucose concentration of the medium was measured,
according to the manufacturer’s instructions, using the
Stanbio Glucose LiquiColor1 (Oxidase) Procedure No. 1070
(Stanbio Laboratory, Boerne, TX, USA). Briefly, 99 ml of the
reagent were added to a 96 microtitre plate (Greiner Bio-One,
Frickenhausen, Germany) prewarmed to 37 uC and 1 ml of
medium sample was added. After another 5 min of incubation
at 37 uC, the glucose concentration was quantified in a
microplate reader (FLUOstar Omega; BMG Labtech,
Ortenberg, Germany) at 500 nm, using water as a reference.
The lactate concentration of the medium was measured,
according to the manufacturer’s instructions, using the LOD-
PAP Method (Diaglobal, Berlin, Germany). Briefly, 99 ml of the
reagent was mixed with 1 ml of medium sample in a 96-well
format multiwell plate and the absorbance was measured at
520 nm in a microplate reader, using water as a reference.
Immunofluorescence staining of ECs inside the MOC
After 4 days in culture, the ECs were fixed inside the
microvascular circuit with cold acetone at 220 uC for 10
min, rinsed twice with PBS for 5 min, incubated with 10% goat
serum in PBS for another 20 min, and then incubated with the
primary antibody, mouse anti-human CD31 (1 : 500; 7.1 mg
ml21; DRFZ, Berlin, Germany), at room temperature (RT) for 2
h. Subsequently, the circuits were washed twice with PBS
followed by incubation with the secondary antibody, Alexa
Fluor1 594 goat anti-mouse (1 : 200, 2 mg ml21; Life
Technologies, Darmstadt, Germany), in the dark at RT for 40
min. After washing, the antibody sheep anti-human vWF-FITC
(1 : 50, 10 mg ml21; Abcam, Cambridge, UK) was added and
incubated at RT for 2 h. Nuclei were counterstained with
Hoechst 33 342 (1 : 1000, 10 mg ml21; Life Technologies,
Darmstadt, Germany). Another immunofluorescence staining
with the primary antibody mouse anti-human VE-Cadherin
(1 : 100, 0.2 mg ml21; Santa Cruz Biotechnology, Heidelberg,
Germany) was carried out: ECs were fixed with 4% PFA for 10
min, rinsed twice with PBS for 5 min and permeabilised with
0.2% Triton X-100 for 5 min. After washing twice with PBS,
staining for primary and secondary antibodies was performed,
as described above. MOC cultures were stained for filamen-
tous actin with Oregon Green1 488 phalloidin (Life
Technologies, Darmstadt, Germany), according to the manu-
facturer’s instructions, in combination with VE-Cadherin.
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Each solvent was added to the compartment inserts of the
MOC and pumped for 1–2 min to ensure even distribution.
Images were taken either by standard fluorescence microscopy
or two-photon microscopy (TriMScope II; LaVision BioTec,
Bielefeld, Germany). All microvascular channels were imaged
through their microscope slide wall. 3D images were recon-
structed from the image stack collected, using Imaris software
(Bitplane, Zurich, Switzerland).
Characterization of shear stress effects
Images of immunofluorescence stained HDMECs were taken
at spots A and B of each microvascular circuit (Fig. 1d) to
monitor flow-induced morphological changes using a stan-
dard fluorescence microscope. HDMEC membranes on the
images were retraced manually for automatic EC recognition.
A connected area recognition algorithm was used to identify
the ECs and calculate the corresponding perimeter, cell size,
centre of gravity, and orientation (spatial unweighted second
moment’s main axis) of each EC. A non-dimensional shape
index (SI) parameter was used to quantify cell elongation that
is defined as:
SI~
4PA
P2
(4)
where A is the area of the cell and P is the perimeter of the cell.
The SI ranges from 0 to 1, where 0 is a straight line and 1 is a
perfect circle. Additionally, the angle of orientation was
measured to quantify the alignment of HDMECs in the flow
direction where 0u is a cell’s main axis aligned perfectly with
the direction of flow and 90u is a cell aligned orthogonal to the
direction of flow.28 The source code was implemented in
Matlab (MathWorks, Ismaning, Germany). The SI and cell
orientation angle for at least 200 cells per image were used for
analysis.
Generation of microchannels structured by femtosecond laser
ablation
A CAM-guided femtosecond laser (TissueSurgeon; Rowiak,
Hannover, Germany) with a wavelength of 1030 nm (pulse
energy = 120 nJ), a pulse duration of 400 fs and a repetition
rate of 10 MHz was used by Rowiak to generate microchannels
as little as 406 40 mm2 into the PDMS material. The laser was
focused through a microscope slide onto the surface of the
PDMS-sheet with a high NA tailor-made objective lens.
Channel writing was carried out by using a high-precision
3D positioning system (Feinmess, Dresden, Germany). The
processing speed and laser pulse energy was set to achieve
smooth and well-defined channels. We used a processing
speed in the range from 50 mm s21 for large channels up to 5
mm s21 for small channels. The channel design was chosen to
reveal minimal achievable diameters and to allow continuous
media flow through each of the branched channels.
The PDMS mould was placed with its channel openings to
the top into a 48-well plate to seed the pre-structured
microchannels with cells. HDMECs were added on top of the
PDMS mould and stained with Calcein AM assay (Life
Technologies, Darmstadt, Germany) after 1 day of cultivation.
Afterwards, the PDMS mould was placed with its channel
openings to the bottom into the tissue compartment of the
MOC, making sure that inlet and outlet channel of the pre-
structured microchannel was placed in line with the channels
of the MOC. Images were acquired by standard fluorescence
microscopy.
Results and discussion
Evaluation of fluid dynamics
We successfully applied mPIV to characterize fluid flow profiles
at different spots of the MOC circuits (Fig. 2a). Thorough
microscopic access to each and every area of the MOC
facilitates in-depth analyses of various other regions of the
MOC and variable MOC designs in the future. Supplementary
video 1 (see ESI3) illustrates the potential for optimal analysis
by microscopy and the operational modus of the peristaltic
micropump membranes of a microfluidic MOC circuit filled
with human red blood cells from a worm’s-eye view. A robust
peristaltic on-chip micropump has been integrated into a
microvascular circuit capable of faultlessly circulating media
at sterile conditions over weeks and months at a flow rate
ranging from 7 ml min21 (lowest frequency) to 70 ml min21
(highest frequency). The frequency of pulsatile operation can
be increased up to 2.4 Hz, which corresponds to a high but still
physiological heart activity of 144 beats per minute in humans.
At this frequency, the shear stress measured at spots A and B
of the microvascular circuit reaches approximately 25 dyn
cm22 (Fig. 2b), which is a physiological shear stress at the
higher end of the scale in microvasculature.29 The mean
velocity increased almost linearly with the pumping frequency.
The pumping frequency used in our experiments (0.476 Hz)
corresponds to less than 30 ‘‘heart-beats’’ per minute
(approximately half of the physiological value of an adult at
rest) to avoid EC loss during early phases of surface coverage.
This phase somehow resembles elements of wound healing in
vivo. As illustrated in Fig. 2a, oscillatory shear stress - another
desired physiological feature - could be implemented into
MOC operation through the micropump design. The waveform
of such oscillation at a certain local position in the
microvasculature depends upon the pumping frequency and
the particular design of a MOC. Certain waveforms in humans
have been associated with certain disease susceptibility.24 This
implies the further evaluation of the MOC platform for
research into such pathological processes of the human
cardiovascular system.
EC source, isolation and culture
Currently, the majority of human EC shear stress research in
microfluidic systems is carried out on human umbilical vein
endothelial cells (HUVECs) due to easy access to large cell
numbers and their high phenotype pliability. We hypothesize
that HDMECs own at least the same pliability of phenotype,
but with a higher potential of rapid in vitro adaptation toward
changing the local environment. Kamm and co-workers, for
example, succeeded in culturing HDMECs in a vertical plane of
microchannels and monitor capillary morphogenesis into
collagen gels in the lateral plane.30,31 In contrast to all other
3592 | Lab Chip, 2013, 13, 3588–3598 This journal is  The Royal Society of Chemistry 2013
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organs of the body, the skin of vertebrates needs to adapt
rapidly to eventually changing external temperatures by
immediate blood vessel contraction or relaxation. Moreover,
the skin of carnivores is the organ with the most pronounced
exposure to repeated injury, due to their aggressive life-style.
These two factors taken together with human longevity might
have selected HDMECs for an unmatched pliability of their
phenotype and a unique potential for neoangiogenesis. Both
factors are of the outmost importance for the establishment of
a functional in vitro equivalent to human vasculature. The
capacity for neoangiogenesis, in particular, is crucial for the
establishment of the second part of human vasculature – the
capillary network of organ equivalents – in MOCs. The latest
discoveries in molecular mechanisms of angiogenesis have
recently been reviewed in detail and underpin the essential
role of local environment including shear stress.32–34 Various
techniques have been described to isolate human ECs from
different tissues. The magnetic bead isolation of ECs after
tissue digestion with CD31 (PECAM-1) MicroBeads was applied
because it is constitutively expressed at the surface of virtually
all types of ECs and is not present on any other cell type apart
from the white blood cell population.35,36 In particular, it is
not expressed on dermal fibroblasts and smooth muscle cells.
The morphology and several endothelial-specific markers were
examined to confirm the endothelial origin. The isolated
HDMECs showed cobblestone-like morphology in phase
contrast and were positive for the endothelial-specific marker
CD31, VE-Cadherin and von Willebrand Factor (vWF). Staining
for 5B5, a fibroblast-specific marker, and a-smooth muscle-
actin, a smooth muscle cell-specific marker, showed no
outgrowth of other cell types. In addition, HDMECs showed
an uptake of Alexa594-labeled ac-LDL after 4 h of exposure. A
mix of dermal fibroblasts and smooth muscle cells served as
the control for all stainings (data not shown). HDMECs could
be cultured for up to eight passages without significant
changes in morphology and marker expression. Our data
indicate that this method is a robust and reproducible way to
isolate CD31-positive HDMECs from human foreskin. The
average number of HDMECs fully covering two microvascular
circuits of a MOC was calculated to be in the range of 26 105
cells. On average, 1 6 107 primary HDMECs after sorting can
be prepared from a single human foreskin. A cell amplification
factor of y3000 holds true between the initial seeding and
passage 7–8 of HDMEC culture, thus enabling the provision of
3 6 1010 cells from a single foreskin. Theoretically, this is
equivalent to 5000 cell-loaded MOCs (two circuits per MOC).
Optimization of preparation and propagation might be
envisioned to further improve the HDMEC yield.
Establishment of stable microvascular circuits in the MOC
A pilot comparison study between EC attachment to fibronec-
tin-coated and air plasma-treated PDMS surfaces revealed an
at least equal adherence of HDMECs to PDMS in static
cultures (Fig. 3a). In addition, plasma treatment has long been
recognised as a viable technique to increase the hydrophilicity
of PDMS microchannels.37–39 Therefore, air plasma treatment
was finally chosen for surface activation during the fabrication
of MOCs. Fibronectin is widely used as a coating material for
EC attachment and cultivation in PDMS-based microfluidic
devices.28,40–42 Although easy to handle at laboratory research
scale, a fibronectin coating procedure may hamper process
speed and sterility at later large industrial scale at high
throughput. PDMS treatment with air plasma in our hands is a
reproducible, fast and scalable method to prepare PDMS-
based microdevices for efficient EC attachment.
Thereafter, a microvascular circuit comprising a peristaltic
micropump, two compartments for later organ equivalent
cultures and connecting microchannels, entirely covered with
Fig. 2 Evaluation of fluid dynamics in the MOC. (a) Example of velocity profiles throughout the four stages of a full pumping cycle (frequency: 0.476 Hz) measured at
the two discrete fluid flow analysis spots to underpin the pulsatile character of the fluid flow (black circle = closed valve, white circle = open valve). (b) Mean velocity
magnitude (mm s21) and corresponding shear stress (dyn cm22) plotted against pumping frequencies (Hz) at both spots.
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a functional HDMEC monolayer, was established in a pulsatile
media flow within 4 days of culture (Fig. 3b). We earlier
demonstrated full circuit coverage with a human EC line
elsewhere.9 Here, we focussed on the rapid establishment of
such a miniaturized human cardiovascular transport system
based on primary HDMECs. In addition, daily tracking of the
metabolic activity of ECs was performed (Fig. 3c). The
increased metabolic activity within the first days of surface
attachment and coverage can be explained by increased
motility and proliferation of cells. Supplementary video 2
(see ESI3) visualises this increased activity in a time-lapse
manner. A system attrition rate of 50% in the early stages of
experiments, primarily caused by contaminations, was effi-
ciently reduced to about 20% during routine MOC use in our
laboratory. Total quality management systems installed in
each and every industrial in vitro testing laboratory might fully
eliminate this ‘‘research lab’’ attrition rate.
ECs maintained adherence to the channel walls and
remained viable, as seen by Calcein red-orange AM staining.
In addition, cells were tested for the uptake of Alexa594-ac-LDL
(Fig. 4a). As no further change in endothelial morphology was
observed after 4 days of cultivation, the experiments were
stopped for analysis. In-depth immunofluorescence analyses
of the tight EC layer at day 4 revealed striking viability and
vascular functionality (Fig. 4a). The HDMECs forming the
microvascular circuit were positive for CD31, vWF and VE-
Cadherin. Furthermore, HDMECs were able to cover all walls
of the channels forming a fluid-tight layer (Fig. 4b and 4c).
Supplementary video 3 (see ESI3) illustrates this blood vessel-
like coverage in combination with functional markers. Such
stable microvascular circuits, on one hand, might act as
biological membranes preventing the transfer of molecules
into the surrounding PDMS slice described recently.43,44 On
the other hand, they might serve as haemocompatible vessel
Fig. 3 Behaviour of HDMECs in the MOC device. (a) Comparison of HDMEC morphology on three different surfaces: (i) untreated, (ii) fibronectin coated and (iii) air
plasma treated PDMS. Air plasma treatment supports equally pronounced adhesion of HDMECs to PDMS surfaces compared to the traditional fibronectin coating, as
illustrated here for static cultures. (b) Initial cell adherence to the bottom of the channels in spots A and B observed after 3 h of static preculture differs significantly
from the fully established tightly closed monolayer of the same areas after 4 days of dynamic tissue culture; a time-lapse video of the first 66 h of EC adherence to the
channel bottom at spot B is provided (see ESI3, supplementary video 2). (c) The metabolic track record for glucose and lactate verifies the expected higher activity
during the surface coverage (cell proliferation and attachment for ‘‘wound healing’’) until day 2 in comparison to steadily decreasing activity within a dormant
‘‘healthy’’ microvasculature (day 3 and 4). Scale bar = 100 mm.
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networks for whole blood circulation, preventing blood
clotting.
Impact of shear stress
When exposed to laminar shear stress, ECs align themselves
and their microfilaments in the direction of the flow.45 In vivo,
ECs in different locations are exposed to different types of
flow, such as laminar, pulsatile and turbulent; the latter, for
example, has been reported to increase turnover.34
Physiological shear stress-induced elongation and flow align-
ment was evident in our MOC cultures plotting the SI and
angle of orientation of HDMECs in the microvascular circuits
generated at pulsatile flow (Q = 40.56 ml min21, t = 5.17 dyn
cm22), against those generated under static culture conditions
(Fig. 4c).46,23 A change in the distribution of filamentous actin
(F-actin) was observed between static and dynamic cultivation
(Fig. 4e). ECs in static conditions are polygonal and F-actin is
organised as a dense band in the periphery of the cell;
Fig. 4 Characterisation of the established HDMEC microvasculature at day 4. (a) Functionality of the established microvascular vessel system was demonstrated (as an
example) for the bottom of spot A by (i) live cell viability staining (Calcein AM assay) and (ii) the uniform distribution of ac-LDL uptake, (iii) CD31 (red), vWF (green)
and (iv) VE-Cadherin expression (red) throughout the entire EC population. Scale bar = 100 mm. (b) Calcein AM assay (red) showed viable and evenly distributed
HDMECs in all areas of the circulation. Scale bar = 2 mm. (c) Image stack taken by two-photon laser scanning microscopy showing HDMECs inside the microchannel
stained against CD31(red) and vWF (green). HDMECs were able to cover all walls of the channels forming a fluid tight layer. Scale bar = 100 mm. (d) Quantification of
cell alignment (angle of orientation) and morphology (shape index, SI) of HDMECs under static and dynamic conditions at spots A and B. Comparisons between static
and dynamic conditions were made by the Student t test with statistical differences established at **: p , 0.01; ***: p , 0.001. (e) Micrographs of the endothelial
monolayer with fluorescently stained actin filaments in (i) dynamic and (ii) static culture conditions are shown. Bundles of stress fibres (green) align along the direction
of flow in dynamically cultured ECs. Scale bar = 50 mm. Nuclei in all images were counterstained with Hoechst 33 342 (blue).
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meanwhile at shear stress of about 5 dyn cm22, F-actin creates
bundles of stress fibres.34 The SI and angle of orientation
differed significantly between static and dynamic cultivation
of ECs in the MOC (Fig. 4d), and were in the range previously
reported for HDMECs in microfluidic devices.28
Finally, we observed equally outstanding cell viability at
spots of analysis in a limited number of indicative long-term
experiments with microvascular MOCs over 14 days (n = 4) of
culture and in a first single microvascular MOC over 32 days
(data not shown).
Preparing MOCs for vascularized multi-organ culture
It remains a formidable challenge to integrate the second
functional part of the human cardiovascular system – the
organ specific capillary network – into the two compartments
of each microvascular MOC circuit left for future organ
equivalent culture. A first successful step toward further vessel
branching and vessel diameter reduction down to a micro-
vessel scale of approximately 40 6 40 mm2 has been
accomplished applying a two-photon laser ablation technique
(Fig. 5). After 1 day of static cultivation, HDMECs were
distributed evenly inside the branched channels (Fig. 5a).
Calcein red-orange AM staining showed viability of the seeded
ECs (Fig. 5b). However, further experiments have to evaluate
the potential for long-term perfused culture inside the MOC.
Collagen or fibrin gels can be used to form sealed channel
connections and prevent leakage during perfused culture.47
Later on, small pores will be introduced into the PDMS mould
by pre-structuring on a silanised wafer48 or punching. Pre-
cultured organoids can then be placed on top, as shown in
Fig. 5a. Optical lithographic techniques have been used by
Kobayashi and co-workers to perform capillary networks in
vitro for implantation in mice.49 Other alternatives to achieve
this goal might include prevascularisation techniques,50,51 the
use of decellularised scaffolds52–54 or tissue printing proce-
dures involving the establishment of capillary networks.55,56
Conclusions
Self-reliant long-term homeostasis of different organ equiva-
lents at a miniaturized organismal scale constitutes a yet
unmatched new and challenging level of in vitro biology in the
near future. These organ equivalents need to rely on an
evolutionarily optimised specialisation of each organ toward
its primary function at a minute organoid level against the
background of strict interdependence of all organs within an
individual microsystem for survival. We hypothesize that
blood circulation through EC-lined microcircuits connecting
organ equivalents with each other in a physiological order is
the first and prime essential requirement to fully emulate
human organismal homeostasis at the microscale. Therefore,
here we have successfully applied soft lithography, replica
moulding and two-photon laser ablation techniques to
establish an incubator independent microvascular circulation
system mimicking the transport function of the human
cardiovascular system at the microscale. It is arranged in a
two-layer glass-PDMS chip the area of a standard microscopic
slide, with channel heights of 100 mm and a total height of 3
mm. Two separate cylindrical tissue culture inserts, each the
area of a standard cavity of a 96-well plate, are positioned in
the microvascular circuit. A robust 4 day procedure applying
pulsatile shear stress has been established to cover all fluid
contact surfaces of the system with a functional, tightly closed
layer of HDMECs. In contrast to the vertical plane HDMEC
growth described in literature,30,31 the entire coverage of our
microvascular system with human ECs render possible
biological haemocompatibility of such a microvascular system
for the first time. The chip layout reduces the circulating fluid
volume in the microvascular transport system down to 10 ml, at
least two orders of magnitude lower than the circulation
volume applied in any of the systems operated with external
pumps and reservoirs. More importantly, tissue culture
inserts, each of a maximum volume of 300 ml, will allow for
the exact adjustment of physiological fluid-to-tissue ratios
once individual organ equivalents are established in the next
development step. While we could already demonstrate the
successful co-culture of human skin biopsies and 3D liver
spheroids over 28 days in the MOC,57 the addition of a fully
vascularized system to such a co-culture has to be implemen-
ted in the future. The fabrication technique is convenient and
versatile, and design changes can be implemented in design-
to-device turnaround times of only 2–3 months. The alignment
and elongation of ECs in the direction of flow, thoroughly
demonstrated in vitro,17,18,58–60 has been monitored in perfect
detail through time-lapse video microscopy. Other microflui-
dic channel designs have been equally efficiently covered with
HDMECs in our laboratories by the technique described. We
Fig. 5 Microchannels structured by Femtosecond lasers seeded with HDMECs.
(a) HDMECs (red) could be distributed evenly in all branched microchannels.
Green colour indicates the autofluorescence of a decellularised dermis placed
exemplarily on top of the PDMS mould. (b) Calcein AM staining (red) showed
excellent viability of the cells after 1 day of static cultivation.
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have generated first indications that once a microvascular
circulation system is established, it eventually has an operat-
ing life of at least 32 days. The unique combination of real-
time video microscopy, live cell imaging and mPIV at one and
the same location of the microvascular circulation system
makes it a perfect tool for the basic investigation of all aspects
of EC migration described,61 such as chemotaxis, duro- or
mechanotaxis,62 haptotaxis,63 or a combination of these
cues.64 This EC motility, as outlined by Young and co-workers,
is critical to fundamental biology, pathology and tissue repair
with the prime focus on understanding vasculogenic and
angiogenic processes.41
Finally, the microvascular transport system described can
now be used for the establishment of organ-specific equiva-
lents of the functional part of the human cardiovascular
system – the tissue – specific capillary network. Here, we will
adhere to our recently published roadmap toward vascularised
‘‘human-on-a-chip’’ models containing a sufficient number of
organs and systems to generate systemic data fully replacing
the animals or human beings currently used.9 That strategy is
well in line with the concept of the Tissue Chip for Drug
Screening initiative of the National Institute of Health, in
collaboration with the Defense Advanced Research Projects
Agency and the U.S. Food and Drug Administration launched
in 2012 (http://www.ncats.nih.gov/research/reengineering/tis-
sue-chip/tissue-chip.html).
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